• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Ac-SDKP

Ac-SDKP

Product ID S1343
Cas No. 120081-14-3
Purity ≥95%
Product Unit SizeCostQuantityStock
5 mg $196.20 Please Inquire
10 mg $335.20 Please Inquire
25 mg $588.70 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ac-SKDP is a pro-angiogenic peptide degradation product of thymosin B4 that regulates hematopoiesis by inhibiting proliferation of hematopoietic pluripotent stem cells (spleen colony-forming units, or CFUs). This peptide exhibits cardioprotective, anti-inflammatory, and anti-fibrotic activities. In animal models of chronic myocardial infarction, Ac-SDKP improves left ventricular function, increases angiogenesis, and decreases infarct size. In hypertensive rats, Ac-SDKP prevents angiotensin II-induced increases in collagen synthesis and cross-linking as well as expression of LOX and TGF-β and activation of NF-κB and lymphocytic immune cells. In other animal models, this peptide prevents fibrosis, decreasing deposition of fibronectin and collagen and decreasing the number of myofibroblasts and macrophages. Ac-SDKP also exhibits nephroprotective activity, inhibiting progression of lupus nephritis in animal models; Ac-SDKP decreases proteinuria, infiltration of inflammatory T cells and macrophages, production of TNF-α, activation of NF-κB, and phosphorylation of Smad2/3, resulting in improvements in renal function.

Product Info

Cas No.

120081-14-3

Purity

≥95%

Formula

C20H33N5O9

Formula Wt.

487.51

IUPAC Name

(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carboxylic acid

Synonym

Goralatide, Seraspenide

Solubility

Soluble in water.

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

S1343 MSDS PDF

Info Sheet

S1343 Info Sheet PDF

References

Song M, Jang H, Lee J, et al. Regeneration of chronic myocardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide Ac-SDKP. Biomaterials. 2014 Mar;35(8):2436-45. PMID: 24378015.

González GE, Rhaleb NE, Nakagawa P, et al. N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats. Clin Sci (Lond). 2014 Jan 1;126(1):85-94. PMID: 23834332.

Zuo Y, Chun B, Potthoff SA, et al. Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis. Kidney Int. 2013 Dec;84(6):1166-75. PMID: 23739235.

Tan H, Zhao J, Wang S, et al. Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice. Int Immunopharmacol. 2012 Dec;14(4):401-9. PMID: 22922317.

Lenfant M, Wdzieczak-Bakala J, Guittet E, et al. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc Natl Acad Sci U S A. 1989 Feb;86(3):779-82. PMID: 2915977.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • S3346

    Silodosin

    α1A-adrenergic antagonist.

    ≥98%
  • F7657

    Ftorafur

    5-fluorouracil prodrug, pyrimidine analog; thym...

    ≥99%
  • C3576

    Citreoviridin A

    Mycotoxin; F1F0 ATP synthase inhibitor.

    ≥95%
  • C0021

    Cafestol Acetate

    Diterpene found in brewed, unfiltered coffee; F...

    ≥98%
  • I5354

    Iniparib

    Cysteine adduct inducer, PARP-1 inhibitor.

    ≥98%
  • C022682

    2-Carbomethoxy-3-thiophenesulfonyl Chloride

    Building block

    ≥98%
  • E7209

    Escitalopram Oxalate

    S-enantiomer of citalopram; SERT inhibitor.

    ≥99%
  • I7559

    Isoliquiritigenin, natural

    Chalcone; SIRT activator, GABA-A positive modul...

    ≥99%
  • A528251

    Angiotensin I/II (1-7)(DP-7)

    Peptide fragment

    ≥95%
  • D3320

    Difenoconazole

    Triazole; 14-α demethylase inhibitor, potentia...

    ≥98%
  • N5767

    Norethindrone

    Steroid hormone, contraceptive; PR agonist.

    ≥98%
  • P6852

    Propafenone Hydrochloride

    β-adrenergic antagonist, Kv1.4 and K2P2 K+ cha...

    ≥98%
  • P6264

    PPQ-102

    Pyramido-pyrrolo-quinoxalinedione; CFTR blocker...

    ≥98%
  • T286161

    Theaflavin

    Polyphenolic compound present in black tea.

    ≥98%
  • N1980

    Neuromedin B, pig

    Endogenous bombesin-related peptide, involved i...

    ≥95%
  • C224760

    CFT-7455

    Degrader of IKZF1/3

    ≥98%
  • L0254

    Lansoprazole

    H+/K+ ATPase inhibitor.

    ≥98%
  • A5228

    Angiogenin

    Small protein, cleaves RNA.

    ≥98%
  • T6832

    Triamcinolone Acetonide

    Synthetic steroid; glucocorticoid agonist.

    ≥98%
  • N859614

    NVP-LDE225

    Smo inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only